Expression of P-glycoprotein in relation to clinical manifestation, treatment and prognosis of adrenocortical cancer

Eur J Cancer. 1993;29A(7):1036-8. doi: 10.1016/s0959-8049(05)80219-9.

Abstract

The presence of P-glycoprotein, associated with multiple drug resistance and present in the normal adrenal cortex, was studied in 15 cases of adrenocortical carcinoma. P-glycoprotein was found in eight tumours; no correlation was found with clinical presentation, steroid production or histological index. 10 patients received mitotane. Remarkably, 3 patients with P-glycoprotein-positive tumours achieved complete remission. On the other hand, 2 patients with P-glycoprotein-negative tumours showed progression of the disease despite mitotane treatment. These findings suggest that the expression of P-glycoprotein in adrenocortical carcinoma is not related to clinical manifestations, steroid production, histological index or response to mitotane therapy.

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Adrenal Cortex Neoplasms / drug therapy
  • Adrenal Cortex Neoplasms / metabolism*
  • Adrenal Cortex Neoplasms / pathology
  • Carrier Proteins / metabolism*
  • Female
  • Humans
  • Male
  • Membrane Glycoproteins / metabolism*
  • Mitotane / therapeutic use
  • Neoplasm Proteins / metabolism*
  • Prognosis

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Carrier Proteins
  • Membrane Glycoproteins
  • Neoplasm Proteins
  • Mitotane